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Background:  Recent studies have shown that transmural delayed enhancement pattern on multidetector computed tomography (MDCT) without 
iodine re-injection immediately after primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI) 
was correlated with non-viable myocardium. Non-invasive assessment of microvascular obstruction (MVO) and interstitial myocardial hemorrhage by 
cardiovascular magnetic resonance (CMR) provides a specific biomarker of severe microvascular dysfunction. The aim of this study was to determine 
whether MDCT enhancement patterns immediately after PCI was related to the presence of severe microvascular dysfunction determined by CMR in 
patients with STEMI.
Methods:  The study population consisted of 99 consecutive patients with a first STEMI successfully treated with PCI. 64-slice MDCT without iodine 
re-injection was performed immediately after PCI. Myocardial enhancement was considered transmural when involving≥75% of myocardial thickness 
(n=43), subendocardial (<75%, n=45)) or normal (n=11). CMR performed within 3 days after primary PCI was used to identify the presence of 
reperfusion hemorrhage and contrast enhancement was used to detect and quantify MVO. A semiquantitative scale score was defined for the 17 left 
ventricular segments to assess the extent of delayed enhanced area determined by MDCT.
Results:  Fifty/99 (51%) patients had MVO and 39 (39%) of them showed myocardial hemorrhage. Patients with MVO and hemorrhagic myocardial 
infarction were more frequently observed in patients with transmural delayed enhancement pattern by MDCT compared to those without transmural 
pattern (95% vs 16%, p<0.0001; 79% vs 9%, p<0.0001, respectively). The total sizes of LGE and MVO correlated with the extent of delayed 
enhancement of MDCT (r2=0.51, p<0.0001; r2=0.46, p<0.0001, respectively).
Conclusion:  Myocardial delayed enhancement immediately following primary PCI without iodine re-injection for STEMI is a reliable method for 
evaluating severe microvascular dysfunction.
